Cargando…
Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288413/ http://dx.doi.org/10.1186/2051-1426-2-S3-P118 |
_version_ | 1782351967491719168 |
---|---|
author | Perez Horta, Zulmarie Gillies, Stephen Boyden, Margaret Hank, Jaquelyn Rahkmilevich, Alexander Sondel, Paul |
author_facet | Perez Horta, Zulmarie Gillies, Stephen Boyden, Margaret Hank, Jaquelyn Rahkmilevich, Alexander Sondel, Paul |
author_sort | Perez Horta, Zulmarie |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4288413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42884132015-01-15 Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors Perez Horta, Zulmarie Gillies, Stephen Boyden, Margaret Hank, Jaquelyn Rahkmilevich, Alexander Sondel, Paul J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288413/ http://dx.doi.org/10.1186/2051-1426-2-S3-P118 Text en Copyright © 2014 Horta et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Perez Horta, Zulmarie Gillies, Stephen Boyden, Margaret Hank, Jaquelyn Rahkmilevich, Alexander Sondel, Paul Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors |
title | Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors |
title_full | Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors |
title_fullStr | Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors |
title_full_unstemmed | Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors |
title_short | Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors |
title_sort | evaluation of novel immunocytokines that preferentially target high or intermediate affinity il-2 receptors |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288413/ http://dx.doi.org/10.1186/2051-1426-2-S3-P118 |
work_keys_str_mv | AT perezhortazulmarie evaluationofnovelimmunocytokinesthatpreferentiallytargethighorintermediateaffinityil2receptors AT gilliesstephen evaluationofnovelimmunocytokinesthatpreferentiallytargethighorintermediateaffinityil2receptors AT boydenmargaret evaluationofnovelimmunocytokinesthatpreferentiallytargethighorintermediateaffinityil2receptors AT hankjaquelyn evaluationofnovelimmunocytokinesthatpreferentiallytargethighorintermediateaffinityil2receptors AT rahkmilevichalexander evaluationofnovelimmunocytokinesthatpreferentiallytargethighorintermediateaffinityil2receptors AT sondelpaul evaluationofnovelimmunocytokinesthatpreferentiallytargethighorintermediateaffinityil2receptors |